Pharmaceutical Industry discussion, review, analysis, news and information. |
« Labopharm Inc. Presented at the Clinical Meeting of American Academy of Pain Management, the Safety Data from 3 U.S. Phase III Trials for Once-Daily Tramadol | Main | STEEPLE Study Revealed Superior Safety Profile of Sanofi-Aventis’ LOVENOX® (Enoxaparin Sodium Injection) Over Unfractionated Heparin (UFH) in Non-Emergent Percutaneous Coronary Intervention (PCI) Patients »
|
Sep10
|
 What: ExL Pharma's Second Annual Merging Electronic Health Records (EHR) and Electronic Data Capture (EDC) Conference
Integrating Patient Information with Drug Development When: September 18-19, 2006
Where: Sheraton Four Points,
Visit the website for more information and click here to register or here to download the brochure. If you want to register by phone, you may call 866.247.9597. Hat tip: Mallory C. Nitchmann of VOXUS, Inc.
|
TrackBack URL for this entry:
« Labopharm Inc. Presented at the Clinical Meeting of American Academy of Pain Management, the Safety Data from 3 U.S. Phase III Trials for Once-Daily Tramadol | Main | STEEPLE Study Revealed Superior Safety Profile of Sanofi-Aventis’ LOVENOX® (Enoxaparin Sodium Injection) Over Unfractionated Heparin (UFH) in Non-Emergent Percutaneous Coronary Intervention (PCI) Patients »
Use these fast growing business social media sites to promote your business, feature your products, spotlight your business leaders, create links, and drive traffic back to your company site, all for free!
BIZZlogos - Add your logo - free link to your site| View Network Map Network Feed List (OPML) Know More Media Network Feed |
PharmaGazette is a member of the Know More Media network of business related blogs.
Here are some current headlines from some of our business publications:
ProductivityGoal | CallCenterScript |
AdHurl | TheBizofKnowledge |
LandingTheDeal | CustomersAreAlways |
HealthCareVox | BrainBasedBusiness |
TheInsurancePolicy | MarketingBlurb |
Write for us About us Contact Advertise Privacy Disclaimer
This weblog is licensed under a Creative Commons License.
Comment Preview